GlassScriptPhysician profile
Ashley E Nutt
NPI 1205131539
$2,426.84
in general payments reported to CMS, 2019-2025
25 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,380 · 2022: $381 · 2023: $215 · 2024: $325 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.96 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $944.86 | 2021-2025 | Proclaim |
| Abbvie INC. | $316.78 | 2021-2024 | |
| Allergan, INC. | $166.66 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.73 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $121.33 | 2021 | |
| Axsome Therapeutics, INC. | $118.01 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $100.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Arbor Pharmaceuticals, INC. | $71.91 | 2021 | |
| Scilex Pharmaceuticals INC. | $55.06 | 2021 | |
| Virtus Pharmaceuticals LLC | $31.93 | 2021 | |
| Almatica Pharma LLC | $31.56 | 2021 | |
| Pfizer INC. | $28.62 | 2021 | |
| Novo Nordisk INC | $22.28 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $21.86 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $20.43 | 2021 | |
| Horizon Therapeutics Plc | $16.94 | 2021 | |
| Lilly USA, LLC | $16.49 | 2024 | Zepbound |
| Currax Pharmaceuticals LLC | $15.26 | 2023 | Nexletol, Nexlizet, Contrave |
| Amgen INC. | $14.45 | 2021 | |
| Biodelivery Sciences International, INC. | $14.28 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.79 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $13.56 | 2021 | |
| Medtronic, INC. | $11.45 | 2021 | |
| Redhill Biopharma INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Nutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.